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Abstract
Background: Mice lacking the preproenkephalin (ppENK) gene are hyperalgesic and show more anxiety
and aggression than wild-type (WT) mice. The marked behavioral changes in ppENK knock-out (KO) mice
appeared to occur in supraspinal response to painful stimuli. However the functional role of enkephalins
in the supraspinal nociceptive processing and their underlying mechanism is not clear. The aim of present
study was to compare supraspinal nociceptive and morphine antinociceptive responses between WT and
ppENK KO mice.
Results: The genotypes of bred KO mice were confirmed by PCR. Met-enkephalin immunoreactive
neurons were labeled in the caudate-putamen, intermediated part of lateral septum, lateral globus pallidus,
intermediated part of lateral septum, hypothalamus, and amygdala of WT mice. Met-enkephalin
immunoreactive neurons were not found in the same brain areas in KO mice. Tail withdrawal and von
Frey test results did not differ between WT and KO mice. KO mice had shorter latency to start paw licking
than WT mice in the hot plate test. The maximal percent effect of morphine treatments (5 mg/kg and 10
mg/kg, i.p.) differed between WT and KO mice in hot plate test. The current source density (CSD) profiles
evoked by peripheral noxious stimuli in the primary somatosenstory cortex (S1) and anterior cingulate
cortex (ACC) were similar in WT and KO mice. After morphine injection, the amplitude of the laser-
evoked sink currents was decreased in S1 while the amplitude of electrical-evoked sink currents was
increased in the ACC. These differential morphine effects in S1 and ACC were enhanced in KO mice.
Facilitation of synaptic currents in the ACC is mediated by GABA inhibitory interneurons in the local
circuitry. Percent increases in opioid receptor binding in S1 and ACC were 5.1% and 5.8%, respectively.
Conclusion: The present results indicate that the endogenous enkephalin system is not involved in acute
nociceptive transmission in the spinal cord, S1, and ACC. However, morphine preferentially suppressed
supraspinal related nociceptive behavior in KO mice. This effect was reflected in the potentiated
differential effects of morphine in the S1 and ACC in KO mice. This potentiation may be due to an up-
regulation of opioid receptors. Thus these findings strongly suggest an antagonistic interaction between
the endogenous enkephalinergic system and exogenous opioid analgesic actions in the supraspinal brain
structures.
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Background
Opioid systems play an important role in numerous func-
tions in the central nervous system (CNS) including pain
modulation, stress-induced analgesia, reproductive activi-
ties, drinking, learning, motor behavior, mental illness
and mood [1,2]. Endogenous opioid peptide precursors
expressed in neurons are enzymatically cleaved to pro-
duce enkephalin, dynorphins and β-endorphin. Cleavage
of the pre-proenkephalin (ppENK) precursor yields met-
enkephalin and leu-enkephalin which are endogenous
ligands of the μ- and δ-opioid receptors [3]. Evidence has
indicated that the endogenous enkephalinergic system is
involved in the antinociceptive response. For example,
oral administration of BL-2401 (inhibitor of the enkepha-
lin-catabolizing enzyme) and RB101 and SCH-32615
(enkephalinase inhibitors) to mice induces a strong,
naloxone-reversible antinociceptive response [4-6].
Intrathecal administration of DAMPGO and DPDPE pro-
duce antinociception via an interaction with spinal opioid
μ- and δ-receptors [7]. Also, an antinociceptive effect was
prevented in mice pre-treated intrathecally with met-
enkephalin antiserum [8].
The role of endogenous opioid peptides has recently been
investigated using knockout (KO) mice [9]. Pre-
proenkephalin deficient mice are healthy but display sig-
nificant behavioral abnormalities. Increased anxiety and
offensive aggressiveness is observed in male [9] and
female [10]mice. In behavioral tests, the ppENK  KO
exhibit more exaggerated responses to painful stimuli
than control wild-type mice (WT). Furthermore, nicotine-
induced antinociception is decreased in mice lacking the
ppENK gene [9,11,12]. The marked behavioral changes in
KO mice appear to occur via the supraspinal response to
painful stimuli [9]. However, the functional role and
mechanism of action of enkephalin in supraspinal nocic-
eptive processing is unclear.
The primary somatosensory cortex (S1) and anterior cin-
gulate cortex (ACC) are two important supraspinal brain
regions mediating discriminative and affective aspects of
pain responses respectively [13-16]. Unit activities and
extracellular field potentials evoked by noxious stimula-
tion of cutaneous tissue have been used for investigation
of nociceptive information processing within the S1 [17-
19] and ACC [20-22]. Administration of morphine caused
a concomitant reduction in the amplitude of noxious-
evoked field potentials, ensemble neuronal unit activities
and evoked synaptic currents recorded in the S1
[19,23,24]. These effects were reversed by naloxone treat-
ment. The effect of morphine could be induced locally by
topical application of morphine to the cortex, resulting in
significant decreases in the pain intensity rating [25]. Fur-
thermore, in an experiment examining the co-registration
of noxious-evoked ensemble unit activities in the S1 and
ACC of behaving rats, a single dose of morphine intraperi-
toneally suppressed the long latency response in the S1
and significantly attenuated early and late responses in
the ACC [26]. However, it is still unclear whether deficien-
cies in the endogenous enkephalin system have any differ-
ential effects on supraspinal pain processing.
Evoked extracellular field potentials in the cortex are com-
monly taken as a measure of nociceptive input to the local
region. However, the interpretation of extracellular field
potential data has inherent ambiguity [27]. The current
source density (CSD) method can be used to accurately
localize the synaptic action by input signals from the S1
and ACC. Extracellular field potentials measured by
multi-channel probes can provide information regarding
the active processes of ionic flow into and out of cells that
generate postsynaptic potentials. The CSD method can be
used to provide sink and source information from such
measurements. We have previously measured synaptic
currents activated by CO2 laser pulses in the S1 or noxious
electrical pulses in the ACC using multichannel probes
and CSD analysis [19,21]. The evoked CSD profiles and
varied stimulation methods allowed us to examine the
temporal and spatial processing of nociceptive synaptic
transmission in the intracortical regions.
To investigate the role of the endogenous enkephalin opi-
oid system in the supraspinal nociceptive response, we
used ppENK knockout (KO) mice. We examined the effect
of endogenous enkephalin deficiency on nociception by
tail-withdrawal, hot-plate and von Frey behavior tests and
the effect of morphine. We characterized and compared
evoked synaptic currents in the S1 and ACC of WT and KO
mice in response to noxious stimuli. The differential
effects and underlying mechanism of exogenous mor-
phine treatment in enkephalin deficient mice was further
examined.
Results
Verification of enkephalin deficiency in KO mice
Immunohistochemical labeling of enkephalin fiber termi-
nals was performed to confirm enkephalin deficiency in
KO mice. Qualitative changes in the labelling of terminals
in different brain regions were observed in low magnifica-
tion microscope images (Figure 1A, WT and B, KO; serial
coronal sections). In WT mice, met-enkephalin immuno-
reactive cell bodies were observed in the lateral globus
pallidus (Figure 1C) and met-enkephalin immunoreac-
tive cell bodies and fibers were labelled in the intermedi-
ated part of the lateral septum (Figure 1D), caudate
putamen (Figure 1E), amygdaloid nuclei (Figure 1F). Less
labelling with the met-enkephalin antibody was detected
in the cingulate cortex (Figure 1G) and sensory motor cor-
tex (Figure 1H) of WT mice. Met-enkephalin immunore-
activity in these regions was barely observed inMolecular Pain 2008, 4:41 http://www.molecularpain.com/content/4/1/41
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corresponding brain sections of KO mice (Figure 1I–N).
The immunohistochemical labelling was consistent in all
WT (n = 9) and KO (n = 6) mice examined.
Behavioral changes and effect of morphine on supraspinal 
nociceptive responses
Von Frey and tail withdrawal tests were carried out to test
the spinal nociceptive behaviors in WT and KO mice. No
significant differences were found in the paw withdrawal
intensity of the von Frey test or the latencies of the tail
withdrawal test in WT (von Frey test, n = 9; withdrawal
test, n = 8) and KO (von Frey test, n = 9; withdrawal test,
n = 17) mice (Figure 2A and 2B). To further test the spinal
withdrawal reflexes, hind limb electromyograms (EMG)
evoked by laser stimuli at the hind paw were measured
and compared in WT and KO mice. The amplitudes of
EMG evoked by incremented laser stimulus duration were
normalized to the maximal response. The trend of ampli-
tude increases did not differ between WT (n = 7) and KO
(n = 5) mice (Figure 2C). The peak amplitudes of EMG
evoked at the 20 ms laser pulse duration were not signifi-
cantly different for WT or KO mice (WT: 0.0334 ± 0.018
mV, n = 7; KO: 0.0287 ± 0.001 mV, n = 5).
In the hot plate test, the latency to the first sign of paw
licking in KO mice was significantly shorter than in WT
mice (p = 0.012, WT: n = 27; KO: n = 43, Figure 2D). The
effect of morphine on supraspinal nociceptive behavior
was further examined using the hot plate test. The analge-
sic effect of morphine was maximal at 40 min after the
morphine injection and was dose-dependent (5 mg/kg,
WT: n = 10; KO: n = 7, 10 mg/kg, WT: n = 9; KO: n = 9,
saline, WT: n = 9; KO: n = 6) (Figure 2E). The percentage
of the maximum possible effect (% MPE) at 40 min was
Comparison of the distributions and densities of immunoreactive enkephalin neurons and fibers in WT and KO mice Figure 1
Comparison of the distributions and densities of immunoreactive enkephalin neurons and fibers in WT and 
KO mice. Low magnification photomicrography of coronal brain sections with immunostaining of enkephalinergic neurons 
and fibers in WT (A) and KO (B) mice. (C) – (N) show higher magnification photomicrography of immunostained brain regions 
of WT mice (C – H) and KO mice (I – N) enlarged from square areas indicated in A and B respectively. The brain regions mag-
nified are: (C), (I) lateral globus pallidus, (D), (J) lateral septum, (E), (K) intermediated part of caudate putamen, (F), (L) amy-
gdaloid nuclear region, (G), (M) cingulate cortex and (H), (N) sensory motor cortex.Molecular Pain 2008, 4:41 http://www.molecularpain.com/content/4/1/41
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significantly higher in KO mice than WT mice after both
dosages of morphine (5 mg/kg, p = 0.049, and 10 mg/kg,
p = 0.007, Figure 2F).
Evoked responses in S1 following laser stimulation
A schematic diagram depicting recording in the S1 by a 16
channel Michigan probe is shown in Figure 3A. The CSD
was calculated from multichannel cortical field potentials
recorded in the contralateral S1 evoked by laser stimula-
tion (10 W, 5~20 ms duration) of the left hind paw.
Evoked responses were reproducible and consistent in
individual animals. Grand averaging was used to average
the evoked responses obtained from different mice, as
described in previous work [19]. The CSD profiles across
the depth of cortical layers in WT (n = 18) and KO (n = 16)
mice following laser stimulation are shown in Figure 3B.
Two major groups of sink currents (sink 1a and sink 2a
&b) were detected in layers II/III, IV and V of the S1 by
laser stimuli with 10 W and 20 ms duration. This finding
was consistent with our previous results in rats. Therefore,
these two distinct sink current components likely repre-
sent the cortical responses of A-delta and C-fiber activa-
tion [19]. The latency and amplitudes of the laser evoked
prominent sink currents in WT and KO mice are listed in
Table 1. The amplitude of the laser evoked sink 1a current
at 20 ms laser pulse duration was -3.37 ± 0.48 mV/mm2
(n = 18) in WT mice and was significantly different from
that evoked in KO mice (-1.60 ± 0.52 mV/mm2, n = 16).
The amplitudes of the major group of sink currents (sink
2a) increased with increasing laser pulse duration (Figure
3C). The amplitudes of sink 2b sink currents were not sig-
nificantly different between WT and KO mice.
Effects of morphine on laser evoked CSD profile and sink 
current components in the S1
The effect of morphine on laser evoked CSD profiles was
tested after stable evoked cortical responses were
obtained. Amplitudes of evoked sink currents were
Comparison of nociceptive behavioural responses and the antinociceptive effect of morphine in WT and KO mice Figure 2
Comparison of nociceptive behavioural responses and the antinociceptive effect of morphine in WT and KO 
mice. Results from the von Frey test (A) tail withdrawal test (B), EMG evoked by incremental laser pulse duration (C), and hot 
plate test (D) are shown. The analgesic effects of morphine (5 mg/kg and 10 mg/kg) on the hot plate test as a function of time 
(E) and 40 min after morphine administration are also shown (F).Molecular Pain 2008, 4:41 http://www.molecularpain.com/content/4/1/41
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Table 1: Amplitudes and latencies of laser-evoked sink currents in the S1 of WT and KO mice.
Amplitude (mV/mm2)L a t e n c y  ( m s )
Sink 1a Sink 2a Sink 2b Sink 1a Sink 2a Sink 2b
WT (n = 18) -3.37 ± 0.40* -5.99 ± 0.70 -1.60 ± 0.10 56.82 ± 3.00 212.46 ± 14.10 270.40 ± 10.80
KO (n = 16) -1.60 ± 0.50 -5.53 ± 0.70 -1.34 ± 0.10 57.19 ± 2.80 211.14 ± 11.20 225.24 ± 12.00
* p = 0.009, Sink 1a of WT v.s. Sink 1a of KO
Laser evoked CSD profiles across cortical layers of the S1 in WT and KO mice Figure 3
Laser evoked CSD profiles across cortical layers of the S1 in WT and KO mice. (A) Schematic diagram of the 
recording scheme. The position of the multichannel probe is overlaid with histological sections from the S1. Cortical layers are 
indicated by roman numerals. Arrow indicates the electrolytic lesion mark in layer V. (B) CSD sweeps across the cortical layers 
in WT (left panel) and KO (right panel) mice. Gray lines indicate the averaged CSD sweeps from individual mice. Black lines 
indicated the grand averaged CSD sweeps from WT (n = 18) and KO (n = 16) mice. Sink currents are in the downward direc-
tion and source currents are in the upward direction. Sink 1a (early component) and sink 2a and sink 2b (late components) 
were identified. All of the evoked CSD profile was evoked by laser stimuli with intensity of 10 W and duration of 20 ms. (C) 
Percent of maximal amplitude change of sink 2a evoked by increment of laser duration.Molecular Pain 2008, 4:41 http://www.molecularpain.com/content/4/1/41
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reduced after 10 mg/kg morphine treatment in both WT
and KO mice. Typical examples of the effect of morphine
on CSD profiles in S1 in both WT and KO mice are shown
in Figure 4A. This result is consistent with our previous
findings [19]. The amplitude of the sink 2a current was
reduced by 66.11 ± 4.52% (10 mg/kg morphine) in WT
mice (n = 8). The suppressive effect was also evident in KO
mice (n = 9) where a 52.31 ± 4.13% (10 mg/kg morphine)
reduction was observed. Statistical analysis of the mor-
phine effect on the amplitudes of sink currents is shown
in Figure 4B. The suppressive effect of morphine was sig-
nificant in sink 2a and sink 2b currents. The effect of mor-
phine in both WT and KO mice was reversed by treatment
with naloxone (0.7 mg/kg).
Evoked responses in ACC following electrical stimulation 
at right hind paw
The multichannel electrode and recording scheme in the
ACC area are illustrated in Figure 5A. The grand average of
CSD sweeps evoked by electrical stimulation of 10 mA,
0.5 ms duration and, 0.1 Hz in the hind paw of WT (n =
4) and KO (n = 4) is shown in Figure 5B. An early small
sink current appeared in upper layer VI. A second promi-
nent sink current, sink 2, was evoked at layer V. A third
sink current was evoked at a longer latency in layer II/III.
Amplitudes and latencies of these sink components are
listed in Table 2. Amplitude of the sink currents increased
with increasing stimulation intensity in WT and KO mice
(sink 2, Figure 5C). The amplitude of the sink 2 current
evoked at 10 mA in KO mice was not significantly differ-
ent from that evoked in WT mice (WT: -0.84 ± 0.10 mV/
mm2, n = 10; KO: -0.91 ± 0.05 mV/mm2, n = 6).
Effect of morphine on the sink current evoked in the S1 by laser pulses (10 W and 20 ms duration) Figure 4
Effect of morphine on the sink current evoked in the S1 by laser pulses (10 W and 20 ms duration). (A) Example 
of laser evoked CSD profiles in the S1 before and after morphine treatment (10 mg/kg) in WT (upper panel) and KO (lower 
panel) mice. (B) Statistical analysis of the effect of morphine on sink 1a, sink 2a and sink 2b in WT and KO mice. Reversibility of 
the effect was evaluated by treatment with naloxone (0.7 mg/kg). * p < 0.05. ** p < 0.01.Molecular Pain 2008, 4:41 http://www.molecularpain.com/content/4/1/41
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Table 2: Amplitudes and latencies of noxious electrically-evoked sink currents in the ACC of WT and KO mice.
Amplitude (mV/mm2)L a t e n c y  ( m s )
Sink 1 Sink 2 Sink 3 Sink 1 Sink 2 Sink 3
WT (n = 18) -0.32 ± 0.08 -0.83 ± 0.11 -0.56 ± 0.12 27.72 ± 0.12 95.17 ± 13.50 192.10 ± 14.10
KO (n = 16) -0.31 ± 0.20 -0.91 ± 0.10 -0.66 ± 0.20 38.70 ± 2.30 91.39 ± 6.40 190.60 ± 17.90
Electrical evoked CSD profiles across cortical layers of the ACC in WT and KO mice Figure 5
Electrical evoked CSD profiles across cortical layers of the ACC in WT and KO mice. (A) Schematic diagram of 
the recording scheme and the electrical stimulation parameters: 10 mA, 0.5 ms duration and 0.1 Hz. The position of the mul-
tichannel probe is overlaid with histological sections of the ACC. Cortical layers are indicated by roman numerals. Arrow indi-
cates the electrolytic lesion mark in layer V. (B) CSD sweeps across the cortical layers in WT (left panel) and KO (right panel) 
mice. Gray lines indicate averaged CSD sweeps from individual mice. Black lines indicate the grand averaged CSD sweeps from 
WT (n = 4) and KO (n = 4) mice. Sink 1, sink 2 and sink 3 were identified. (C) Percent of maximal amplitude change of sink 2 
evoked by increment of electrical intensity of stimulus.Molecular Pain 2008, 4:41 http://www.molecularpain.com/content/4/1/41
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The effect of morphine on evoked CSD profiles in the ACC
We have found previously that current sinks evoked by
peripheral noxious stimuli in rats are potentiated by mor-
phine treatment [21]. Enhancement of the evoked sink
current, induced by 10 mA, 0.5 ms duration, 0.1 Hz elec-
trical stimulation in the hind paw, was confirmed in the
present study in both WT and KO mice. A typical example
is shown in Figure 6A. Statistical analysis of the effect of
morphine on the sink current components is shown in
Figure 6B. Sink 2 and sink 3 currents were significantly
enhanced by morphine (10 mg/kg). After morphine injec-
tion, there was a 137.70 ± 11.35% and 278.41 ± 55.90%
increase of sink 2 and sink 3 currents respectively in WT
mice, whereas the increase of sink 2 and sink 3 currents in
KO mice was 183.45 ± 25.87% and 365.34 ± 103.78%
respectively. The effect of morphine in both WT and KO
mice was reversed by naloxone (0.7 mg/kg).
Effect of morphine on simultaneously recorded responses 
in the S1 and ACC
Morphine evoked opposite responses in the ACC and S1
when recording measurements were made separately. This
raised the question whether the responses were due to
morphine or variations in the sampling condition. There-
fore, the effect of morphine on the evoked responses in
the ACC and S1 was examined simultaneously as shown
with the placement of recording probes in Figure 7A. In
our pilot study, we found that the responses in the ACC
evoked by laser pulses were too small and variable to eval-
uate reliably. In order to obtain strong, reliable responses
for comparison between the ACC and S1, we used strong
electrical stimuli, 10 mA, 0.5 ms duration and 0.1 Hz, as
the noxious stimulation. An early and marked sink cur-
rent was evoked in layer IV of S1 at 20.72 ± 1.57 ms with
an amplitude of -18.99 ± 4.163 mV/mm2 after electrical
stimuli. The stimulating thresholds for evoking sink cur-
rents ranged from 0.03 to 0.12 mA in WT mice and from
0.06 to 0.18 mA in KO mice. Prominent sink current com-
Effect of morphine on the sink current in the ACC evoked by high electrical intensity stimulation Figure 6
Effect of morphine on the sink current in the ACC evoked by high electrical intensity stimulation. (A) Example 
of CSD profiles evoked by electrical stimulation (10 mA, 0.5 ms duration and 0.1 Hz) in the hind paw before and after mor-
phine treatment (10 mg/kg) in WT (upper panel) and KO (lower panel) mice. (B) Statistical analysis of the effect of morphine 
on sink 1, sink 2 and sink 3 in WT and KO mice. Reversibility of the effect was evaluated by treatment with naloxone (0.7 mg/
kg). * p < 0.05. ** p < 0.01.Molecular Pain 2008, 4:41 http://www.molecularpain.com/content/4/1/41
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ponents in layers II/III and V of S1 (Table 3) and layer V
of ACC could be evoked by intense electrical currents (10
mA) applied at the hind paw and recorded simultane-
ously (Figure 7B). Typical effects of morphine (5 mg/kg,
10 mg/kg and 20 mg/kg) are shown in Figure 7B.
With 5 mg/kg morphine, the amplitude of sink 2 in the
ACC evoked by electrical stimulation was 96.2 ± 7.6% of
the control amplitude in WT mice (n = 8) and 133.2 ±
18.9% of the control amplitude in KO mice (n = 9). Mor-
phine decreased the sink current in layer II/III in the S1 to
91.8 ± 4.0% of the control amplitude in WT mice (n = 8)
and 63.1 ± 10% of the control amplitude in KO mice (n =
9).
With 10 mg/kg morphine, the amplitude of the sink cur-
rent in the ACC increased to 137.3 ± 11.3% of the control
amplitude in WT mice (n = 9) and 183.4 ± 25.3% of the
control amplitude in KO mice (n = 7). In the S1, mor-
phine decreased the sink current evoked by electrical stim-
ulation to 79.7 ± 13.0% of the control amplitude in WT
mice (n = 9) and 47.7 ± 7.0% of the control amplitude in
KO mice (n = 7).
With 20 mg/kg morphine, the amplitude of the sink cur-
rent in the ACC increased to 126.9 ± 6.8% of the control
amplitude in WT mice (n = 8) and 183.7 ± 28.9% of the
control amplitude in KO mice (n = 6). In the S1, mor-
phine decreased the CSD profile evoked by electrical stim-
ulation to 61.5 ± 9.9% of the control amplitude in WT
mice (n = 8) and 29.7 ± 6.7% of the control amplitude in
KO mice (n = 6). The effect of morphine was reversed in
both the S1 and ACC by intraperitoneal injection of
naloxone (0.7 mg/kg).
Effect of GABAB agonist and antagonist on evoked CSD 
responses in the ACC
The enhancing effect of morphine on CSD profiles in the
ACC has been investigated previously in rats [21]. We
have previously shown that the effect of morphine is
mediated by local opioid interneurons. Several reports
have implicated GABAergic interneurons in opioid local
action in ACC circuitry [28,29]. To further examine the
role of GABAergic interneurons in the effect of morphine,
the GABAB receptor agonist; SKF 97541, and GABAB recep-
tor antagonist; CGP 55845, were administered after mor-
phine injections in WT and KO mice. Example sweeps of
sink 2 current in layer V of the ACC were averaged from 20
sweeps of cortical response following electrical stimula-
tion of the hind paw with 10 mA, 0.5 ms duration and 0.1
Hz (Figure 8A). Morphine (10 mg/kg) significantly
increased the evoked CSD response (sink 2) in layer V of
the ACC (Figure 8A &8B, KO mice, n = 4, p = 0.01; WT
mice, n = 4, p = 0.05). Morphine induced potentiation of
the evoked CSD response (sink 2) in the ACC was
decreased after 30 min of 0.3 mg/kg SKF 97541 treatment
(KO: n = 4, p = 0.005; WT: n = 4, p = 0.003). The inhibi-
tory effect of SKF 97541 on the evoked response in the
ACC was reversed by 10 mg/kg CGP 55845 (KO: n = 4, p
= 0.02; WT: n = 4, p = 0.0001).
Alteration of μ-opioid receptor responses in the ACC and 
S1
Morphine enhanced both the excitatory effect in the ACC
and suppressive effect in the S1 in KO mice. It is unlikely
that these enhancements are due to the endogenous
release of enkephalin because the deficiency of enkepha-
lin in fiber terminals was demonstrated for KO mice. A
likely explanation is up-regulation of opiod receptors as
reported previously [30]. μ-opioid receptor immunoreac-
tivity in the ACC and S1 is shown in Figure 9A. The distri-
bution and density of μ-opioid receptors in the ACC and
S1 are qualitatively different in WT (n = 8) and KO (n = 8)
mice. The ratio of specific and non-specific binding at opi-
oid receptors was compared using Western blot data (Fig-
ure 9B). The difference in ratio in WT (n = 6) and KO (n =
7) mice was not statistically different but there is a trend
that receptor binding in the ACC and S1 is higher in KO
mice than WT mice. The receptor binding from KO mice
was 105.8% that of receptors from WT mice in the ACC
and 105.1% of WT mice in the S1.
Discussion
The present study revealed that ppENK deficiency mainly
influenced the nociceptive behavioral responses mani-
fested at the supraspinal level. The antinociceptive effect
of morphine was dose-dependent in WT mice. The effect
of morphine was enhanced in KO mice as shown by the
hot plate test. Acute nociceptive responses in the cortical
regions indicated by alteration of CSD profiles did not dif-
fer in KO mice compared to WT mice, indicating that the
enkephalin system is not directly involved in acute and
Table 3: Amplitudes and latencies of noxious electrically-evoked sink currents in the S1 of WT and KO mice.
Amplitude (mV/mm2) Latency (ms)
Sink 1 Sink 2 Sink 3 Sink 1 Sink 2 Sink 3
WT (n = 18) -18.99 ± 4.10 -2.80 ± 0.40 -4.14 ± 0.80 20.72 ± 1.50 39.26 ± 2.50 96.30 ± 6.10
KO (n = 16) -23.10 ± 5.20 -2.78 ± 0.30 -4.06 ± 0.90 20.05 ± 1.30 39.53 ± 2.90 90.30 ± 3.60Molecular Pain 2008, 4:41 http://www.molecularpain.com/content/4/1/41
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phasic nociceptive transmission. Systemic morphine
treatment resulted in opposing effects on noxiously
evoked synaptic responses in the S1 and ACC. The effect
of morphine in both regions was significantly enhanced
in KO mice. This result strongly indicates the potential
antagonistic interaction between endogenous enkepha-
linergic system and exogenous opioid analgesic media-
tion in the supraspinal region. Enhancement of the effect
of morphine may be due to up-regulation of μ-opioid
receptor expression when enkephalin release is deficient.
Morphine-enhanced nociceptive synaptic responses in the
ACC were blocked by a GABAB receptor agonist indicating
that the endogenous enkaphalinergic system is involved
in the anti-nociceptive response through the inhibitory
GABAB receptor.
Effect of ppENK deficiency on supraspinal pain behavior
ppENK deficient (KO) mice exhibit normal pain responses
in von-Frey and tail-withdrawal tests and similar leg with-
drawal EMG activities as WT mice. Increased pain sensitiv-
ity in KO mice was only observed in the hot-plate test. In
the hot plate test, the nocifensive behavior involved lick-
Effect of morphine on simultaneously recorded evoked cortical responses in the S1 and ACC Figure 7
Effect of morphine on simultaneously recorded evoked cortical responses in the S1 and ACC. (A) Schematic dia-
gram of the recording scheme of the multichannel probes placed in the S1 and ACC regions. (B) Example sweeps of sink cur-
rents in the ACC layer V (upper panel) and S1 layer II/III (lower panel) evoked by the high intensity electrical stimulation (10 
mA, 0.5 ms duration and 0.1 Hz) in the hind paw. Example sweeps of evoked cortical sink currents after morphine treatment 
(5 mg/kg, 10 mg/kg and 20 mg/kg) and reversal by naloxone treatment were demonstrated. (C) Statistical analysis of the effect 
of morphine on simultaneously recorded S1 and ACC evoked sink currents. Data are presented as mean ± SEM. Amplitude of 
the sink current after morphine injection is expressed as a percentage of the amplitude of the sink current measured before 
morphine injection. * p < 0.05.Molecular Pain 2008, 4:41 http://www.molecularpain.com/content/4/1/41
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ing, flinching and head, trunk and limb coordination.
Compared to the spinal reflexive behaviors measured by
the von Frey and tail withdrawal tests, these behaviors are
more complex, organized and unlearned behaviors and
involve purposeful actions requiring supraspinal sensory
processing [31]. This finding was consistent with a previ-
ous study in which ppENK KO mice expressed sensitive
nociceptive responses to supraspinal behavior tests
[9,10,12,32]. KO mice also displayed reduced exploratory
activity in an unfamiliar environment [9]. Evidence indi-
cated that brief exposure to short, emotionally-arousing,
non-noxious stress, such as holding and novel environ-
ments, leads to an immediate and transient hyperalgesia
[33-35]. It is unlikely that this effect resulted in the hyper-
algesia observed in KO mice in the hot plate test. Firstly,
WT and KO mice were exposed to the same testing envi-
ronment and protocol. Secondly, restraint would have
had a greater effect in the tail withdrawal test where the
rats were held inside a cloth. However, the tail withdrawal
test did not show any significant difference between WT
and KO mice. Therefore, the hyperalgesia observed in KO
mice can be attributed to the genetic factors leading to
alteration of physiological responses, indicating that
endogenous enkaphalins are involved in the modulation
of nocifensive behavioral responses.
Laser evoked CSD in the S1
Two distinct sink current components were observed in
the S1 following brief CO2 laser pulses applied at the hind
paw of WT and KO mice. The intracortical layer distribu-
tion and activation pattern of these two components were
similar with those previously found in rats [19]. The early
component of the laser-evoked responses observed in the
present study was consistent with previously reported
"laser-evoked potential (LEP)" findings [24,36,37] and
the negative peak in intracortical recording following radi-
ant heat stimulation of rat hind paw [38]. The cortical
layer location and initiation timing of sink Ia suggest that
this sink current is derived from a depolarization of the
dendrites of spiny stellate neurons that receive inputs
from specific thalamic afferents [39]. One important dif-
ference between the previous study in rats and the results
in mice presented here is that the sink current activated in
the deep layer was absent in mice. Also, the amplitude of
the sink Ib current identified in rats was small. Deep cor-
tical layers receive terminations from projection neurons
of the posterior thalamic nucleus [40-42]. The thalamic
afferent terminals in the deep cortical layers are sparse and
not as dense as those in layer IV [42]. The synchronous,
excitatory postsynaptic current in the deep layer would be
more dispersed compared with that activated in the gran-
ular layer. Therefore, one possible reason that the sink cur-
rent is absent in the deep layer is that the small amplitude,
deep layer, early sink current in the early component was
cancelled out in the grand averaged sweeps.
Nociceptive cortical responses following laser stimulation
exhibited similar late onset latency of sink current in layer
III–IV and layer V–VI as found previously in rats [19]. The
sink source activation patterns and cortical layer distribu-
tion of the late component were similar to that of the early
component. Thus, the excitatory synaptic events activated
by the late onset thalamocortical afferents followed a sim-
ilar intracortical layer-specific pathway to that in the early
Effect of GABAB agonist and antagonist on the evoked sink currents in the cortical layer V of the ACC Figure 8
Effect of GABAB agonist and antagonist on the evoked sink currents in the cortical layer V of the ACC. (A) The 
electrical stimulation (10 mA, 0.5 ms duration and 0.1 Hz) was applied in the right paw of the mice. Example sweeps of evoked 
sink currents in layer V of the ACC under before and after treatment with morphine, SKF 97541 and CGP55845. (B) Statistical 
analysis of the effects of morphine, SKF 97541 and CGP55845 on the layer V sink current in the ACC. * p < 0.05. ** p < 0.01.Molecular Pain 2008, 4:41 http://www.molecularpain.com/content/4/1/41
Page 12 of 18
(page number not for citation purposes)
component. These early and late components are most
likely multiple spinal pathways which transfer informa-
tion from cutaneous nociceptive A-delta and C fibers to
the SI in mice. However, similar amplitude of sink cur-
rents activated by graded stimuli in both WT and KO mice
indicates that endogenous enkephalin peptide was not
directly involved in normal nociceptive transmission.
Electrical stimulation evoked CSD in the ACC
One early sink in layer V and two major sink currents in
layer V and II/III were detected in the ACC following nox-
ious electrical stimulation in both WT and KO mice.
Although there was a difference in the layer distribution of
the sink and source currents, similar evoked CSD profiles
in the ACC were observed in rats in our previous study
[21]. The earliest sink in layer VI, located near the layer V/
VI border, has a shorter latency than that in layer II/III and
Detection and measurement of μ-opioid receptors by immunostaining and Western blotting Figure 9
Detection and measurement of μ-opioid receptors by immunostaining and Western blotting. (A) Immuoreactive 
μ-opioid-receptors were stained in the S1 and ACC of WT and KO mice. Micrographs of μ-opioid-receptors (100× magnifica-
tion) are shown in the upper panel. Micrographs at higher magnification are shown in the lower panel. Locations that were 
immunopositive for μ-opioid-receptors are indicated by square boxes in the left panel. (B) Western blot data provided a quan-
titative measurement of μ-opioid receptors in the cortical region of WT and KO mice. The μ-opioid receptor band is located 
at 43 kDa (arrow heads). Non-specific binding was used as an internal control (56 kDa). (C) The relative quantities of μ-opioid 
receptor were measured by taking the ratio of specific and non-specific binding in the S1 and ACC of WT (n = 6) and KO (n = 
7) mice. Data are presented as the mean ± SEM.Molecular Pain 2008, 4:41 http://www.molecularpain.com/content/4/1/41
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likely reflects activation by thalamocortical afferent pro-
jections to cingulate neurons in deeper layers [43-46]. The
early sink current in layer II/III was accompanied by a
more superficial source current. This arrangement sug-
gests that afferent fibers terminate on the spines of verti-
cally oriented ascending dendrites of layer II/III pyramidal
neurons [47], creating local sink currents and a distal
source current in their apical dendrites [45,48,49]. Nocic-
eptive-specific neurons in ACC layers V and VI have been
described in several studies [24,50,51]. Strong activation
of the layer II/III sink current by medial thalamus (MT)
stimulation in previous studies suggests that sink currents
in layer II/III may receive direct excitatory synaptic inputs
from the MT [24,50,51]. Similar studies have demon-
strated major thalamic projections to layers II/III and V in
this brain region [43-45,52]. There was no significant dif-
ference in the evoked sink current in the ACC in WT and
KO mice. Thereby indicating that nociceptive synaptic
transmission in the thalamocingulate pathway is not
mediated by the endogenous opioid system.
Differential effect of morphine in the S1 and ACC
Morphine administration induced dose-dependent
behavioral analgesia in both WT and KO mice. This anti-
nociceptive effect was enhanced in KO mice. The analgesic
effect was reflected in the suppressive effect of morphine
on the activated, C-fiber related synaptic current in the S1
of WT mice. The enhanced antinociceptive effect during
behavioral tests was also observed as a result of the sup-
pression of evoked synaptic currents in the S1 of the KO
mice. Systemic administration of morphine has been
shown to produce analgesia at spinal and supraspinal lev-
els [53,54] and C-fiber evoked ensemble neuronal activi-
ties are susceptible to morphine treatment [24]. However,
we cannot exclude the possibility that this C-fiber
response suppressive effect is exerted at the spinal level
[23]. Direct evidence has shown that morphine may act
directly and locally in the S1, as evidenced by suppression
of the sensory rating in the formalin test or inhibition of
noxiously-evoked neurotransmitter release [25,55].
Morphine resulted in enhancement effects in the ACC, in
contrast to the suppressive effect observed in the S1. This
finding is consistent with previous results in rats where
peripheral noxious afferent-activated synaptic currents
were enhanced following morphine treatment [21]. This
effect was mediated by local intracortical circuitries. We
have provided evidence of the involvement of GABA
interneurons in this enhancement effect. The enhance-
ment was attenuated by a GABAB receptor agonist. The
effect of the GABA receptor agonist was reversed by a
GABAB receptor antagonist, indicating that the response is
specific to GABAB  receptors. Evidence for morphine
enhancement of excitatory synaptic transmission through
inhibition of GABAergic interneurons has been found in
the hippocampus and the periaqueductal grey matter [56-
58]. In addition, the interactions between GABA and opi-
oid receptor agonists in the antinociceptive effect and opi-
oid-conditional response have been studied previously
[28,59]. In the medial prefrontal cortex, thalamocingulate
terminals make synapses on GABAergic interneurons as
well as principal neurons [45]. This arrangement may ena-
ble GABAergic interneurons to inhibit cingulate principal
neurons via feedforward inhibition. Moreover, the pres-
ence of GABAergic terminals, both pre- and post-synaptic
from thalamocingulate synapses, may enable disinhibi-
tion of the interneurons following activation of thalmoc-
ingulate afferents [29,60].
μ-Opioid receptor up-regulation in the cortical region of 
KO mice
Differential effects on the evoked synaptic currents in the
S1 and ACC were produced by exogenous morphine treat-
ment. The effect of morphine, whether suppressive or
enhancing, was greater in KO mice than WT mice. The
enhancement cannot be attributed to endogenous
enkephalin release as the KO mice were shown to be defi-
cient in enkephalin. Opioid receptor up-regulation has
been observed when endogenous enkephalin release is
deficient [30] or when mice were chronically treated with
a morphine antagonist [61]. It has been suggested that
proenkephalin peptides are tonically active at mu opioid
receptors in brain regions where the receptors were up-
regulated in the deficient state [30]. We found 5.8% and
5.1% increases in opioid receptor binding in the ACC and
S1 respectively in the present study in KO mice compared
to WT mice. Previous quantitative autoradiography stud-
ies to detect the level of opioid receptor subtypes in the
brain of enkephalin knockout mice showed that the larg-
est changes were observed in limbic regions. The percent
increase of opioid receptor binding in KO mice is between
7.8 and 18% in the ACC [30]. Although our finding of
receptor up-regulation is consistent with previous studies,
there is a discrepancy between the percentage increase of
the receptor up-regulation and the percentage changes in
the behavioral scores and evoked cortical responses fol-
lowing morphine treatment. Thus, up-regulation of opi-
oid receptors may only be partially responsible for the
increase in sensitivity to exogenous morphine treatment
and the potentiated morphine effect in both the S1 and
ACC. Other mechanisms, such as the regulation of post-
receptor signal transduction and the anti-opioid system,
may also be involved [62,63]. Opioid receptor up-regula-
tion can also be induced by chronic opioid antagonist
treatment and it has been suggested that this regulation is
associated with alteration of proteins involved in receptor
trafficking, reducing constitutive internalization of opioid
receptors [61]. Chronic opioid treatment not only impairs
opioid receptor function but also alters G protein cou-
pling events resulting from receptor activation. Qualita-Molecular Pain 2008, 4:41 http://www.molecularpain.com/content/4/1/41
Page 14 of 18
(page number not for citation purposes)
tive changes of components of opioid receptor-coupled
signalling pathways are the predominant mode of opioid
adaptation [62]. In addition to adaptations at the receptor
level, recent studies have indicated that endogenous neu-
ropeptides may also modulate the effects of morphine
and endogenous opioid peptides [64,65]. Administration
of morphine results in the release of anti-opioid peptides
that attenuate the effects of morphine. Hence, anti-opioid
peptides may participate in morphine tolerance[63]. It
has been demonstrated that chronic treatment with an
opioid antagonist resulted in a reduction of morphine tol-
erance [66]. Interestingly, preproenkephalin KO mice also
show reduced morphine tolerance [32]. Therefore, the
deficiency of endogenous enkephalin in KO mice may
alter the endogenous anti-opioid system, in turn enhanc-
ing the effect of exogenous morphine. The enhancement
of morphine-induced analgesia in KO mice, as observed
in the present study, indicates that there is a potential
antagonistic interaction between the endogenous
enkephalinergic system and exogenous opioid analgesic
action occurring in supraspinal brain structures.
Conclusion
The present findings are consistent with the view that the
S1 and ACC play different roles in pain signal processing
and that the endogenous opioid system is regulated differ-
ently in these two brain regions. In the sensory-discrimi-
native aspects of pain, distinctive intra-cortical synaptic
currents in the S1 may mediate specific nociceptive infor-
mation regarding the intensity and location of pain. Both
the spinal and cortical pathways make it possible for S1 to
integrate information from nociceptive A-delta and C
fiber inputs. In the affective aspect of pain signal process-
ing, our CSD analysis results indicate that intra-cortical
synaptic currents in the ACC are different from activated
currents in the S1. The cingulate cortical layer II/III sink
currents initiate an intracortical, polysynaptic excitation
which may relay nociceptive information to other cortical
and subcortical structures. The endogenous enkephalin
system was not involved in acute nociceptive transmission
in the spinal cord, and in the S1 and ACC. However, mor-
phine preferentially suppressed the supraspinal related
nociceptive behavior in KO mice. This effect was evident
in the potentiated differential effects of morphine on the
S1 and ACC in KO mice. This potentiation may be due to
the up-regulation of opioid receptors. This study supports
a potential antagonistic interaction between the endog-
enous enkephalinergic system and exogenous opioid
analgesic action in supraspinal brain structures.
Methods
Animals
Preproenkephalin KO mice (B6.129-Penk-rstm1Pig; back-
ground strain C57BL/6J) were purchased from Jackson
Laboratories (Bar Harbor, ME, USA). Homozygous
mutant offsprings were bred and polymerase chain reac-
tion (PCR) was used to confirm the genotype of the
homozygous Penk-/- mice. Using the primers, Penk com-
mon-E31, Penk WT-E1R, and Penk KO-neoRL, a 700-bp
and 500-bp fragments were amplified from WT and KO
mice respectively. The 700-bp band was specific to WT
mice while the 500-bp band was specific in KO mice.
B6.129-Penk-rstm1Pig (KO) and control C57BL/6J (WT)
mice (25–35 g body weight) were housed in groups of five
in a room with a 12 h light/dark cycle at 22°C with free
access to food and water. All experiments were carried out
in accordance with the guidelines established by the
Academia Sinica Institutional Animal Care and Utiliza-
tion Committee. Efforts were made to minimize animal
suffering and reduce the number of animals used.
Tail-withdrawal test
Mice were restrained gently in a cotton cloth bag and half
of the tail was immersed from the tip in water (49°C). The
latency of tail-withdrawal was determined from three tri-
als with 30 s intervals between each measurement.
Hot plate test
A metal hot-plate was maintained at 53 ± 0.5°C. The time
to when the mouse first exhibited nocifensive behaviour
(flicked or licked its hind paw) was determined. The cut-
off time was 60 s for the first sign of nocifensive behavior.
Von Frey test
A von Frey filament was attached to a force transducer
(Model 1601C, IITC, Woodland Hills, CA). The mice were
placed in a hanging cage with a mesh wire floor and the
von Frey filament was applied against the plantar surface
of the hindpaw with increasing force until the filament
started to bend and the paw was withdrawn. A digital rea-
dout showed the final force before the paw withdrawal.
This value was taken as the threshold of mechanical noci-
ception (von Frey response). The threshold of the von Frey
response was determined from the mean of ten trials.
Effect of morphine on tail-withdrawal and hot-plate 
response
Morphine was administrated intraperitoneally (5 or 10
mg/kg) after testing the baseline response for the hot-plate
test. To study the time course of the effect of morphine,
the hot-plate latency was recorded 10, 25, 40 and 55 min
after morphine injection and then converted to % MPE. %
MPE = (post-stress latency - baseline latency)/(cut-off
time - baseline latency)*100.
Surgical operation for electrophysiological measurements
Mice were initially anesthetized with 4% halothane (in
100% O2) in an acrylic box. Mice were then anesthetized
with 2% halothane (in 100% O2) for the duration of the
surgery. Body temperature was maintained at a minimumMolecular Pain 2008, 4:41 http://www.molecularpain.com/content/4/1/41
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of 36.5°C via a homeothermic blanket system (Model 50-
7079, Harvard Apparatus, USA). A craniotomy was per-
formed over the skull regions covering the S1 and ACC
regions. Small parts of the dura over S1 and ACC were
carefully removed using a 23-gauge needle. Warm paraffin
was applied to keep the cortical surface moist. Electrocar-
diographs were performed to monitor the heart rate. After
surgical preparation, animals were anesthetized with 0.75
– 1.0% halothane and a mixture of nitrous oxide/oxygen
during the recording session. The depth of anaesthesia
was checked and maintained periodically by pinching the
tail so that no overt body movement or acceleration of the
heart rate was observed.
Electrical stimulation
Two 23-gauge needles were inserted into the hind paw
and used to deliver bipolar electrical stimulation (0.3 – 10
mA, 0.5 ms duration, 0.1 Hz) by an isolated pulse stimu-
lator (Model 2100, A-M System Inc., USA). The anode was
placed about 4 mm distal to the cathode.
Laser stimulation
The laser pulse was generated from a surgical CO2 laser
(Model 20 CH, Direct Energy Inc., CA, USA) and pro-
duced a radiation beam in the infrared (10.6 mm wave-
length). The maximum power output was 20 W and the
pulse duration was adjustable. A built-in calibration sys-
tem measured the peak power of laser pulses. A hand-held
laser probe was used for directing the beam. During the
laser stimulation, the experimenter held the laser probe
and projected the laser beam to targets on the hind paw.
Skin of the hind digits, paw and heel was stimulated with
four pulses at a frequency of 0.9 Hz (10 W, 5 ~20 ms dura-
tion). An averaged electrophysiological recording based
on 20 stimulations was obtained and no visible damage
to the skin was observed. A delay of at least 15 min was
taken before the same skin site was stimulated again.
Recording evoked field potentials in the S1 and ACC
Extra-cellular field potentials evoked by the electrical
pulses described above were mapped first in the S1 region
(~1 mm posterior and 3 mm lateral to bregma). The posi-
tion resulting in maximal positive field potential
responses to hind paw electrical stimulation was located
and designated as the insertion point for the Michigan
probe (16 contact points, 150 μm interval spacing). The
probe was inserted perpendicular to the cortical surface.
Another Michigan probe was used to record the extracel-
lular field potentials in the ACC (~2.5 mm anterior and 1
mm lateral to bregma; probe inserted 40° from vertical).
An Ag-AgCl reference electrode was placed in the nasal
cavity. The sampling rate of recorded analog signals was 6
kHz and data were processed using a multichannel data
acquisition system (TDT Inc., USA) and a personal com-
puter.
Current source densities method
A five-point formula [27,67] was adopted for the time
span and sampling variations in each recording session in
order to smooth the spatial sampling variability. The
extracellular current, Im was derived from the second spa-
tial derivations of the extracellular field potentials, φ, and
was calculated with the finite difference formula:
where h is the distance between successive measuring
points (150 μm in the present investigation), and x is the
coordinate perpendicular to the cortical layer. The
remaining constants are as follows: n = 2, k = 4, a0 = -2, a±
1 = 0 and a± 2 = 1.
Recording of electromyograms on the hind leg
Bipolar stainless steel hook electrodes were inserted into
the gluteus maximus and biceps femoris muscles respec-
tively. Signals with 5 kHz sampling rate and 10 Hz high
pass were obtained using a Cyberamp 380 system (Axon
Inc., USA), 1202 AD conversion card (ICP DAS Inc., Tai-
wan) and a custom-designed acquisition program using
Borland C++ Builder (National Tsing-Hua University, Tai-
pei, Taiwan). Summation of rectified EMGs was per-
formed off-line using a data processing program in Matlab
(The MathWorks, Inc., USA).
Drugs administration
Morphine (5 mg/kg, 10 mg/kg and 20 mg/kg) and
naloxone (0.7 mg/kg) were dissolved in physiological
saline and administrated by intraperitoneal injection. SKF
97541 (0.3 mg/kg, TOCRIS, UK) and CGP 55845 (10 mg/
kg, TOCRIS, UK) were dissolved in saline solution and
administrated by intraperitoneal injection.
Verification of electrode placement
At the end of the experiment, a small lesion was made by
passing an anodal current (30 μA, 5 s) to the deepest elec-
trode of the Michigan probe. Another lesion was made at
the same lead after the Michigan probe was withdrawn by
1000 μm. The brains were fixed by perfusion with normal
saline followed by 10 % formalin. The brains were sliced
in 50-μm-thick coronal sections using a cryosection and
the sections were stained with cresyl violet (Sigma, USA).
Digital images of each section were obtained and showed
clear electrode tracks and lesion markers in the S1 or ACC
regions. The mice atlas of Paxinos & Waston [68] was used
as a reference when detailed cortical layer structures were
estimated. The positions of some recording points were
estimated by determining their distance from two lesion
locations.
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Data Analysis
Based on the CSD data analysis in our previous study [21],
sink or source currents were identified by their relatively
prominent presence in specific locations at specific corti-
cal depths and based on their consistency across different
animals. Two distinct components of the sink currents
were evoked by laser pulses, and were identified in the S1
with early and late latencies respectively. Three separate
components of the sink currents were evoked by electrical
stimuli, and were identified at different cortical depths
and different latencies in the ACC. The peak latencies and
amplitudes of sink and source currents evoked by the elec-
trical stimuli and laser pulses were determined from CSD
data in individual animals. The data recorded in behavio-
ral and electrophysiological experiments were obtained
from WT mice and KO mice and from different treatment
groups. The statistical significance of changes after drug
application was determined using the Student's t-test and
ANOVA analysis. Turkey's post hoc tests were used to
detect the sources of group differences revealed by the
ANOVAs. P < 0.05 was considered statistically significant.
Immunohistochemistry
Anesthetized animals (WT and KO, n = 6 per group) were
perfused with 0.9% NaCl and subsequently with 4% para-
formaldehyde in 0.1 M phosphate buffered saine (PBS,
pH 7.4). The brains were removed, post fixed for 72 h, sec-
tioned at 50 μm on a cryosection and processed for immu-
nohistochemistry. The sections were incubated with
normal goat serum for 1 h and then reacted with rabbit
polyclonal anti-met-enkephalin antibody (AB5026,
Chemicon, USA) and anti-μ-opioid receptor antibody
(AB5511, Chemicon, USA), at dilutions of 1:200 and
1:2000 respectively for 24 h at 4°C. Immunohistochemis-
try was performed using the avidin-biotin elite solution
for 1 h (ABC kit, Vector Laboratories, CA). Staining was
visualized using 0.03% 3,3-diaminobenzidine (DAB) and
0.07% H2O2 in Tris buffer (pH 7.4).
Western blotting
All brain tissue lysis steps were completed at 4°C. Tissue
samples were homogenized in 100 μL ice cold lysis buffer
with 1× protease inhibitor. The samples were lysed for 1 h
on ice with occasional tapping. Samples were then centri-
fuged at 20,000 g for 30 min at 4°C. The supernatant was
removed and the pellet left behind. The concentration of
protein in the pellet was measured using a spectropho-
tometer. Protein samples were diluted to the same con-
centration and run on SDS-PAGE. After transferring, the
membrane was blocked with 4% skim milk in TBS, and
incubated at room temperature for at least 1 h or at 4°C
overnight. The membrane was washed with TBST (TBS
with 0.1% Tween-20) three times. The primary antibody
solution was added in TBS with 0.5% skim milk, incu-
bated at room temperature for 1 h (antibody titer =
1:1000 ~1: 2500). The membrane was washed with TBST
three times. The secondary antibody solution (anti-rabbit
IgG) was added in TBS with 0.5% skim milk, incubated at
room temperature for 1 h (antibody titer = 1:5000). The
membrane was washed three times with TBST and soaked
in BCIP/NBT substrate solution. After the color devel-
oped, the membrane was washed with H2O2 to stop the
reaction and then let dry.
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